Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS02 with Metformin in T2DM
NCT03317028Phase 2Completed
- Sponsor
- Center Laboratories, Inc.
- Start
- Oct 2017
- Primary completion
- Apr 2020
- Countries
- 2
01
Overview
A Phase 2 trial of CS02 + placebo in type 2 diabetes mellitus (T2DM), sponsored by Center Laboratories, Inc.. Started Oct 2017; status: completed.
02
Drugs
CS02 + placebo
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03317028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317028.